Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US
Whichello C, Van Overbeeke E, Janssens R, Bywall KS, Russo S, Veldwijk J, Cleemput I, Juhaeri J, Levitan B, Kuebler J, Smith M, Hermann R, Englbrecht M, Hueber A, Comanescu A, Harding S, Simoens S, Huys I, De Bekker-Grob EW (2019)
Publication Type: Journal article
Publication year: 2019
Journal
Book Volume: 10
Abstract
Objectives: Patient preference information (PPI) is gaining recognition among the pharmaceutical industry, regulatory authorities, and health technology assessment (HTA) bodies/payers for use in assessments and decision-making along the medical product lifecycle (MPLC). This study aimed to identify factors and situations that influence the value of patient preference studies (PPS) in decision-making along the MPLC according to different stakeholders.
Authors with CRIS profile
Matthias Englbrecht
Lehrstuhl für Innere Medizin III
Axel Hueber
Department of Medicine 3 – Rheumatology and Immunology
Involved external institutions
Katholieke Universiteit Leuven (KUL) / Catholic University of Leuven
Belgium (BE)
Uppsala University
Sweden (SE)
Sanofi-Aventis Groupe
France (FR)
Belgian Health Care Knowledge Centre / Federaal Kenniscentrum voor de Gezondheidszorg / Centre Fédéral d'Expertise des Soins de Santé (KCE)
Belgium (BE)
Erasmus University Rotterdam (EUR) / Erasmus Universiteit Rotterdam
Netherlands (NL)
European Institute of Oncology / Istituto Europeo di Oncologia (IEO)
Italy (IT)
Janssen Global Services, LLC
United States (USA) (US)
Amgen Inc.
United States (USA) (US)
Takeda Pharmaceutical Company Limited
Japan (JP)
AstraZeneca Germany
Germany (DE)
Belgium (BE)
Uppsala University
Sweden (SE)
Sanofi-Aventis Groupe
France (FR)
Belgian Health Care Knowledge Centre / Federaal Kenniscentrum voor de Gezondheidszorg / Centre Fédéral d'Expertise des Soins de Santé (KCE)
Belgium (BE)
Erasmus University Rotterdam (EUR) / Erasmus Universiteit Rotterdam
Netherlands (NL)
European Institute of Oncology / Istituto Europeo di Oncologia (IEO)
Italy (IT)
Janssen Global Services, LLC
United States (USA) (US)
Amgen Inc.
United States (USA) (US)
Takeda Pharmaceutical Company Limited
Japan (JP)
AstraZeneca Germany
Germany (DE)
How to cite
APA:
Whichello, C., Van Overbeeke, E., Janssens, R., Bywall, K.S., Russo, S., Veldwijk, J.,... De Bekker-Grob, E.W. (2019). Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.01009
MLA:
Whichello, Chiara, et al. "Factors and Situations Affecting the Value of Patient Preference Studies: Semi-Structured Interviews in Europe and the US." Frontiers in Pharmacology 10 (2019).
BibTeX: Download